Talk of 'solid returns for emerging markets' is generally met with a raised eyebrow from investment veterans.Afterall, there are few obvious similarities between the...
Type ‘dog longevity podcast’ into any app and you’ll find comedians, YouTubers and tech billionaires musing about miracle drugs that could help dogs live...
Britain’s attitude towards its leading edge medicines industry has long been strangely cool.The NHS has preferred cut-price generic drugs to pioneering treatments which could...